Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,350 | 12,620 | -84,620 | -16,240 | N/A |
| Depreciation Amortization | 0 | 0 | 0 | 2,000 | N/A |
| Other Working Capital | -15,900 | -13,130 | 30,310 | 33,120 | N/A |
| Other Operating Activity | -3,940 | -6,670 | 66,560 | -1,180 | 0 |
| Operating Cash Flow | $-11,490 | $-7,180 | $12,250 | $17,700 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 8,860 | 9,220 | -1,440 | -750 | N/A |
| Other Investing Activity | 9,960 | 12,170 | -70,500 | 43,910 | 0 |
| Investing Cash Flow | $18,820 | $21,390 | $-71,940 | $43,160 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 10,700 | 5,040 | 61,830 | -740 | 0 |
| Financing Cash Flow | $10,700 | $5,040 | $61,830 | $-740 | $N/A |
| Exchange Rate Effect | 100 | 570 | -480 | -320 | N/A |
| Beginning Cash Position | 13,840 | 13,990 | 11,990 | 60,120 | N/A |
| End Cash Position | 31,980 | 33,820 | 13,650 | 71,460 | N/A |
| Net Cash Flow | $18,140 | $19,830 | $1,650 | $11,340 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,490 | -7,180 | 12,250 | 17,700 | N/A |
| Free Cash Flow | -11,490 | -7,180 | 12,250 | 17,700 | 0 |